Midday Watch: Aquinox (AQXP), Exact Sciences Corp. (EXAS), Humana Inc. (HUM)

Aquinox Pharmaceuticals Inc. (AQXP) is one of Thursday’s notable stocks in decline, down 24.05% to $6.00. The nosedive is attributed to results from the company’s Phase 2 LEADERSHIP randomized clinical trial investigating the therapeutic potential of AQX-1125 in treating pain in patients with bladder pain syndrome/interstitial cystitis (BPS/IC). Aquinox said that while AQX-1125 demonstrated a […] View the full post at: Midday Watch: Aquinox (AQXP), Exact Sciences Corp. (EXAS), Humana Inc. (HUM) Related posts: Gilead Sciences Announces Large Buyback BofA Needs $35 Billion in Additional Capital Gilead Sciences is in Great Health